Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lenalidomide and Rituximab in Untreated Indolent Non-Hodgkin's Lymphoma
NCT01316523Phase 2Terminated
- Sponsor
- University of California, Davis
- Start
- Dec 2010
- Primary completion
- Sep 2023
- Countries
- 1
01
Overview
A Phase 2 trial of lenalidomide in Non-Hodgkin lymphoma (NHL), sponsored by University of California, Davis. Started Dec 2010; status: terminated.
02
Drugs
lenalidomide
03
Conditions
Non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT01316523.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01316523.